Publication:
Made in Europe: Will artemisinin resistance emerge in French Guiana?

dc.contributor.authorMathieu Nacheren_US
dc.contributor.authorPhilippe J. Guérinen_US
dc.contributor.authorMagalie Demar-Pierreen_US
dc.contributor.authorFélix Djossouen_US
dc.contributor.authorFrançois Nostenen_US
dc.contributor.authorBernard Carmeen_US
dc.contributor.otherCentre Hospitalier Andree Rosemonen_US
dc.contributor.otherUniversite des Antilles et de la Guyaneen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:03:54Z
dc.date.available2018-10-19T05:03:54Z
dc.date.issued2013-05-08en_US
dc.description.abstractResistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory from France make it impossible for the system to adapt to the problem of total inaccessibility of an important part of the malaria problem. Transmission is high in these areas and gold miners self-medicate with erratic regimens of artemisinin combinations, thus creating perfect conditions for the emergence of resistance. What needs to be done is being done, but within the limits of national law, with some results. However, facing the same difficult problem, Suriname shows more flexibility and is doing much better than French Guiana despite having lower resources. Local authorities in French Guiana cannot overrule the laws that block appropriate malaria care from reaching a third of malaria-exposed persons. Thus the health authorities in France should take immediate calibrated legislative and financial measures to avoid a predictable disaster. © 2013 Nacher et al.; licensee BioMed Central Ltd.en_US
dc.identifier.citationMalaria Journal. Vol.12, No.1 (2013)en_US
dc.identifier.doi10.1186/1475-2875-12-152en_US
dc.identifier.issn14752875en_US
dc.identifier.other2-s2.0-84876988296en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/31921
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84876988296&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleMade in Europe: Will artemisinin resistance emerge in French Guiana?en_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84876988296&origin=inwarden_US

Files

Collections